Furthermore, since SC144 is a gp130 inhibitor and IL-6/gp130 axis is important in both polarization of TAMs and cancer cell growth25–28,32–34, we investigated whether IL-6 plays an important role in the anti-tumor efficacy of SC144@HABN + anti-PD-L1 combo therapy. Here, IL6 is linked to cancer.